Universal Health International Group Holding Ltd
02211
Company Profile
Business description
Universal Health International Group Holding Ltd distributes and retails pharmaceutical products in Northeast China. It sells prescription and OTC products, healthcare products, medical devices, and other personal and family care products. The company operates its business through two segments: Distributions and Retails, out of which, majority of revenue is earned by Distributions Segment.
Contact
No. 14-1, Bei Yi Zhong Road
Tiexi District
Liaoning Province
Shenyang
CHNSector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
30 June 2026
Employees
1,198
Stocks News & Analysis
stocks
Strong result for ASX insurer but not the new norm
Stellar first half profits but increasing competition will lower future rate increases.
stocks
Eli Lilly earnings: Weak Orforglipron obesity data weighs down a strong quarter
With today’s share drop, we think Lilly stock looks fairly valued.
stocks
Solid 2025 for A-REIT but development activity will weigh on 2026
Positive news for income investors as yield exceeds 5%.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,117.60 | 41.00 | 0.45% |
| CAC 40 | 7,698.52 | 44.48 | -0.57% |
| DAX 40 | 24,081.34 | 81.52 | -0.34% |
| Dow JONES (US) | 44,015.73 | 159.88 | -0.36% |
| FTSE 100 | 9,129.71 | 33.98 | 0.37% |
| HKSE | 24,906.81 | 47.99 | 0.19% |
| NASDAQ | 21,449.20 | 0.82 | -0.00% |
| Nikkei 225 | 41,820.48 | 761.33 | 1.85% |
| NZX 50 Index | 12,911.86 | 67.23 | 0.52% |
| S&P 500 | 6,386.68 | 2.77 | -0.04% |
| S&P/ASX 200 | 8,844.80 | 37.70 | 0.43% |
| SSE Composite Index | 3,647.55 | 12.42 | 0.34% |